We divided all prostate cancer samples of the studies included in the meta-analysis into three groups, based on their ERG expression level: ERG overexpression-positive samples, ERG intermediate samples, and ERG overexpression-negative samples (Figure S2). Here, ERG is linked to prostate carcinoma.